5.36 USD
▲+0.12+2.49%
盘后 5.24 +0.19%
2026-08-03
市值
$47.66M
市盈率
—
EPS
-1.37
股息率
—
52 周区间
0.72 – 20.32
成交量
36.16K
Beta
1.05
目标价
16.33
52W 低 0.7252W 高 20.32
价格走势
公司简介
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07,...